South East Asia Swine Vaccines Market to 2032
Overview
The South East Asia Swine Vaccines Market is expected to reach a 1.74 USD Billion by 2032 and is projected to grow at a CAGR of 6.33% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.06
Forecast, 2032 (USD Billion)
1.74
CAGR, 2024 - 2032
6.33%
Report Coverage
Asia-Pacific
South East Asia Swine Vaccines Market 2018-2032 USD Billion
South East Asia Swine Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.06 USD Billion
- Projected Market Size (2032): 1.74 USD Billion
- CAGR (2025-2032): 6.33%
Key Findings of South East Asia Swine Vaccines Market
- The South East Asia Swine Vaccines Market was valued at 1.06 USD Billion in 2024.
- The South East Asia Swine Vaccines Market is likely to grow at a CAGR of 6.33% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Virus in Pathogen Segment accounted for the largest share of the market with a revenue of 0.71 USD Billion
- The fastest growing segment Ingelvac in Product Segment grew Fastest with a CAGR of 9.60% during the forecast period from 2024 to 2032.
South East Asia Swine Vaccines Market Scope
South East Asia Swine Vaccines Market Segmentation & Scope
Indication
- Others
- Glaesserella Parasuis
- Porcine Parovirus
- Porcine Pneumonia
- Foot-And-Mouth Disease (FMD)
- Swine Fever
- Porcine Circovirus Associated Disease (PCV/PCVD)
- Porcine Reproductive and Respiratory Syndrome (PRRS)
Pathogen
- Bacteria
- Virus
Technology
- Others
- Toxoid Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
Distribution Channel
- Others
- E-commerce Platforms
- Retail Pharmacies
- Hospitals and Clinics
Product
- Clear The False Spirit
- Ruiyuanshu
- Refute
- Ruifute-Wang
- Shield
- Suigen
- Vepured
- Ruilan
- Progressis
- Coglapix
- Navet-Asfvac & Avac Asf Live
- Enteroporc Coli Ac
- Parvoruvax
- Ecoporc Shiga
- Salmoporc
- Hyogen
- Others
- Circovac
- Yuan Ke Xin
- Enradin
- Bioaftogen
- Enterisol
- Cirbloc M Hyo
- Prevacent
- Improvac
- Porcilis
- Ingelvac
Route of Administration
- Others
- Subcutaneous
- Intramuscular
South East Asia Swine Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.06 USD Billion |
| Market Value in 2032 | 1.74 USD Billion |
| CAGR (2025-2032) | 6.33% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication,Pathogen,Technology,Distribution Channel,Product,Route of Administration |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 1.06 USD Billion in 2024
- Key Country: China, leading in terms of revenue with value of 481.85 USD Million in 2024.
Segments and Scope
-
South East Asia Swine Vaccines Market to 2032, By Indication
- Porcine Reproductive and Respiratory Syndrome (PRRS) is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 254.27 USD Billion in the year 2024.
- Porcine Reproductive and Respiratory Syndrome (PRRS) is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 8.00 % in forecast period 2025-2032.
-
South East Asia Swine Vaccines Market to 2032, By Pathogen
- Virus is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 705.15 USD Billion in the year 2024.
- Virus is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 6.89 % in forecast period 2025-2032.
-
South East Asia Swine Vaccines Market to 2032, By Technology
- Inactivated Vaccines is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 373.15 USD Billion in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 6.93 % in forecast period 2025-2032.
-
South East Asia Swine Vaccines Market to 2032, By Distribution Channel
- Hospitals and Clinics is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 378.49 USD Billion in the year 2024.
- Hospitals and Clinics is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 6.75 % in forecast period 2025-2032.
-
South East Asia Swine Vaccines Market to 2032, By Product
- Ingelvac is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 174.52 USD Billion in the year 2024.
- Ingelvac is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 9.60 % in forecast period 2025-2032.
-
South East Asia Swine Vaccines Market to 2032, By Route of Administration
- Intramuscular is the largest segment in South East Asia Swine Vaccines Market to 2032 with a revenue of 487.23 USD Billion in the year 2024.
- Intramuscular is the Fastest growing segment in South East Asia Swine Vaccines Market to 2032 with a Growth rate of 6.98 % in forecast period 2025-2032.
South East Asia Swine Vaccines Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Zoetis Services LLC | |||
| Boehringer Ingelheim International GmbH | |||
| Ceva | |||
| Jinyu Biotechnology Co., Ltd. | |||
South East Asia Swine Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
South East Asia Swine Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South East Asia Swine Vaccines Market is segmented based on Segmentation Indication,Pathogen,Technology,Distribution Channel,Product,Route of Administration.
South East Asia Swine Vaccines Market was valued at USD 1.06(Revenue in USD Billion) in 2024.
South East Asia Swine Vaccines Market is projected to grow at a CAGR of 6.33% during the forecast period of 2024 to 2032.
The Virus segment is expected to dominate the South East Asia Swine Vaccines Market, holding a largest market share of 0.71 USD Billion in 2024
South East Asia Swine Vaccines Market Scope
South East Asia Swine Vaccines Market Segmentation & Scope
Indication
- Others
- Glaesserella Parasuis
- Porcine Parovirus
- Porcine Pneumonia
- Foot-And-Mouth Disease (FMD)
- Swine Fever
- Porcine Circovirus Associated Disease (PCV/PCVD)
- Porcine Reproductive and Respiratory Syndrome (PRRS)
Pathogen
- Bacteria
- Virus
Technology
- Others
- Toxoid Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
Distribution Channel
- Others
- E-commerce Platforms
- Retail Pharmacies
- Hospitals and Clinics
Product
- Clear The False Spirit
- Ruiyuanshu
- Refute
- Ruifute-Wang
- Shield
- Suigen
- Vepured
- Ruilan
- Progressis
- Coglapix
- Navet-Asfvac & Avac Asf Live
- Enteroporc Coli Ac
- Parvoruvax
- Ecoporc Shiga
- Salmoporc
- Hyogen
- Others
- Circovac
- Yuan Ke Xin
- Enradin
- Bioaftogen
- Enterisol
- Cirbloc M Hyo
- Prevacent
- Improvac
- Porcilis
- Ingelvac
Route of Administration
- Others
- Subcutaneous
- Intramuscular
Frequently Asked Questions
The South East Asia Swine Vaccines Market is segmented based on Segmentation Indication,Pathogen,Technology,Distribution Channel,Product,Route of Administration.
South East Asia Swine Vaccines Market was valued at USD 1.06(Revenue in USD Billion) in 2024.
South East Asia Swine Vaccines Market is projected to grow at a CAGR of 6.33% during the forecast period of 2024 to 2032.
The estimated market value of the South East Asia Swine Vaccines Market for final year is USD 1.74 (USD Billion).
South East Asia Swine Vaccines Market Company Profiling
Frequently Asked Questions
The South East Asia Swine Vaccines Market is segmented based on Segmentation Indication,Pathogen,Technology,Distribution Channel,Product,Route of Administration.
South East Asia Swine Vaccines Market was valued at USD 1.06(Revenue in USD Billion) in 2024.
South East Asia Swine Vaccines Market is projected to grow at a CAGR of 6.33% during the forecast period of 2024 to 2032.
The estimated market value of the South East Asia Swine Vaccines Market for final year is USD 1.74 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 7500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.